ScholarIQanswers from OpenAlex
Radiopharmaceutical Chemistry and Applications
TopicLeading institutions, researchers & key papers
Radiopharmaceutical Chemistry and Applications is a topic indexed in ScholarIQ from OpenAlex.
What is known about Radiopharmaceutical Chemistry and Applications?
ScholarIQrecord summary
This cluster of papers focuses on the development, synthesis, and application of radiopharmaceuticals for PET and SPECT imaging, targeted therapy, radioimmunotherapy, and alpha particle therapy in cancer treatment. It covers topics such as coordinating radiometals, chelators, dosimetry, and the use of specific radionuclides for therapeutic purposes.
How many works does Radiopharmaceutical Chemistry and Applications have?
ScholarIQindexed works
Radiopharmaceutical Chemistry and Applications has 141 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Radiopharmaceutical Chemistry and Applications?
ScholarIQopenalex
The OpenAlex for Radiopharmaceutical Chemistry and Applications is on the source record.
What are the most-cited papers on Radiopharmaceutical Chemistry and Applications?
ScholarIQmost cited works
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
Masashi Mukoyama, Kazuwa Nakao, Kiminori Hosoda, Sachie Suga, Yoshihiko Saito, Yoshihiro Ogawa, Gotaro Shirakami, Michihisa Jougasaki, Keisuke Obata, Hirofumi Yasue
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
Arthur T. Porter, Alexander McEwan, John Powe, Robert Reid, D.G. McGowan, Himu Lukka, J.R. Sathyanarayana, V.N. Yakemchuk, G.M. Thomas, L.E. Erlich, Juanita Crook, Karen Y. Gulenchyn, Kelvin Hong, Carl A. Wesolowski, J. H. Yardley
Dosimetry of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
John Violet, Price Jackson, Justin Ferdinandus, Shahneen Sandhu, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Sue Ping Thang, Peter Eu, Mark Scalzo, Declan G. Murphy, Scott Williams, Rodney J. Hicks, Michael S. Hofman
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, René Blom, Jan Tennvall, Bo Lennernäs, Ulf Petersson, Dag Clement Johannessen, M. Sokal, K. Pigott, Jeffrey Yachnin, Michael Garkavij, Peter Strang, Johan Harmenberg, B. Bolstad, Øyvind S. Bruland
Where is Radiopharmaceutical Chemistry and Applications research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Radiopharmaceutical Chemistry and Applications is open access?
ScholarIQopen access share
40%OPEN ACCESS